19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Micronuclei in Cord Blood Lymphocytes and Associations with Biomarkers of Exposure to Carcinogens and Hormonally Active Factors, Gene Polymorphisms, and Gene Expression: The NewGeneris Cohort

      research-article
      1 , 2 , 3 , 4 , 5 , 6 , 1 , 7 , 8 , 9 , 6 , 10 , 1 , 8 , 11 , 7 , 1 , 5 , 12 , 13 , 14 , 10 , 8 , 11 , 13 , 15 , 2 , 16 , 17 , 18 , 3 , 5 , 14 , 15 , 14 , 2 , 15 , 16 , 17 , 19 , 3 , 20 , 6 , 16 , 19 , 13 , 21 , 13 , 9 , 19 , 21 , 13 , , 9 , 13 , the NewGeneris Consortium
      Environmental Health Perspectives
      National Institute of Environmental Health Sciences

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Leukemia incidence has increased in recent decades among European children, suggesting that early-life environmental exposures play an important role in disease development.

          Objectives: We investigated the hypothesis that childhood susceptibility may increase as a result of in utero exposure to carcinogens and hormonally acting factors. Using cord blood samples from the NewGeneris cohort, we examined associations between a range of biomarkers of carcinogen exposure and hormonally acting factors with micronuclei (MN) frequency as a proxy measure of cancer risk. Associations with gene expression and genotype were also explored.

          Methods: DNA and protein adducts, gene expression profiles, circulating hormonally acting factors, and GWAS (genome-wide association study) data were investigated in relation to genomic damage measured by MN frequency in lymphocytes from 623 newborns enrolled between 2006 and 2010 across Europe.

          Results: Malondialdehyde DNA adducts (M 1dG) were associated with increased MN frequency in binucleated lymphocytes (MNBN), and exposure to androgenic, estrogenic, and dioxin-like compounds was associated with MN frequency in mononucleated lymphocytes (MNMONO), although no monotonic exposure–outcome relationship was observed. Lower frequencies of MNBN were associated with a 1-unit increase expression of PDCD11, LATS2, TRIM13, CD28, SMC1A, IL7R, and NIPBL genes. Gene expression was significantly higher in association with the highest versus lowest category of bulky and M 1dG–DNA adducts for five and six genes, respectively. Gene expression levels were significantly lower for 11 genes in association with the highest versus lowest category of plasma AR CALUX® (chemically activated luciferase expression for androgens) (8 genes), ERα CALUX® (for estrogens) (2 genes), and DR CALUX® (for dioxins). Several SNPs (single-nucleotide polymorphisms) on chromosome 11 near FOLH1 significantly modified associations between androgen activity and MNBN frequency. Polymorphisms in EPHX1/2 and CYP2E1 were associated with MNBN.

          Conclusion: We measured in utero exposure to selected environmental carcinogens and circulating hormonally acting factors and detected associations with MN frequency in newborns circulating T lymphocytes. The results highlight mechanisms that may contribute to carcinogen-induced leukemia and require further research.

          Citation: Merlo DF, Agramunt S, Anna L, Besselink H, Botsivali M, Brady NJ, Ceppi M, Chatzi L, Chen B, Decordier I, Farmer PB, Fleming S, Fontana V, Försti A, Fthenou E, Gallo F, Georgiadis P, Gmuender H, Godschalk RW, Granum B, Hardie LJ, Hemminki K, Hochstenbach K, Knudsen LE, Kogevinas M, Kovács K, Kyrtopoulos SA, Løvik M, Nielsen JK, Nygaard UC, Pedersen M, Rydberg P, Schoket B, Segerbäck D, Singh R, Sunyer J, Törnqvist M, van Loveren H, van Schooten FJ, Vande Loock K, von Stedingk H, Wright J, Kleinjans JC, Kirsch-Volders M, van Delft JHM, NewGeneris Consortium. 2014. Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: The NewGeneris Cohort. Environ Health Perspect 122:193–200;  http://dx.doi.org/10.1289/ehp.1206324

          Related collections

          Most cited references49

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: not found
            • Book: not found

            Conspectus florae Graecae / auctore E. de Halácsy.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Epidemiology of childhood cancer.

              The present contribution reports childhood cancer incidence and survival rates as well as time trends and geographical variation. The report is based on the databases of population-based cancer registries which joined forces in cooperative projects such as Automated Childhood Cancer Information System (ACCIS) and EUROCARE. According to these data, which refer to the International Classification of Childhood Cancer, leukemias, at 34%, brain tumors, at 23%, and lymphomas, at 12%, represent the largest diagnostic groups among the under 15-year-olds. The most frequent single diagnoses are: acute lymphoblastic leukemia, astrocytoma, neuroblastoma, non-Hodgkin lymphoma, and nephroblastoma. There is considerable variation between countries. Incidence rates range from 130 (British Isles) to 160 cases (Scandinavian countries) per million children. Incidence rates have shown an increase over time since the mid of the last century. In Europe, the yearly increase averages 1.1% for the 1978-1997 period and ranges from 0.6% for the leukemias to 1.8% for soft-tissue sarcomas. The probability of survival has risen considerably over the past decades, with the EUROCARE data showing an improvement of the relative risk of death by 8% when comparing the 2000-2002 time span to the 1995-1999 period. Regarding the years 1995-2002, the data show an overall 5-year survival probability of 81% for Europe and similar values for the USA. The data presented here describe the cancer situation with a specific, European focus. They are drawn from population-based cancer registries that ensure excellent data quality, and as a consequence represent the most valid European population-based data existing at present. It is also apparent that not all countries have data available from nationwide childhood cancer registries, a situation which warrants further improvement. 2010 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Environ Health Perspect
                Environ. Health Perspect
                EHP
                Environmental Health Perspectives
                National Institute of Environmental Health Sciences
                0091-6765
                1552-9924
                19 November 2013
                February 2014
                : 122
                : 2
                : 193-200
                Affiliations
                [1 ]Epidemiology, Biostatistics, and Clinical Trials, Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliera Universitaria (AOU) San Martino-Istituto Nazionale per la Ricerca sul Cancro (IST), Genoa, Italy
                [2 ]Hospital del Mar Medical Research Institute, Barcelona, Spain
                [3 ]Molecular and Environmental Epidemiology, National Institute of Environmental Health, Budapest, Hungary
                [4 ]BioDetection Systems b.v., Amsterdam, the Netherlands
                [5 ]National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece
                [6 ]Cancer Studies and Molecular Medicine, University of Leicester, Leicester, United Kingdom
                [7 ]Department of Social Medicine, University of Crete, Heraklion, Crete, Greece
                [8 ]Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
                [9 ]Laboratory of Cell Genetics, Faculty of Science and Bio-engineering, Vrije Universiteit Brussel, Brussels, Belgium
                [10 ]Division of Biostatistics, Leeds Institute for Genetics, Health and Therapeutics, University of Leeds, Leeds, United Kingdom
                [11 ]Center for Primary Health Care Research, Lund University, Malmö, Sweden
                [12 ]Genedata AG, Basel, Switzerland
                [13 ]Department of Toxicology and Toxicogenomics, Maastricht University, Maastricht, the Netherlands
                [14 ]Division of Environmental Medicine, Norwegian Institute of Public Health, Oslo, Norway
                [15 ]Department of Public Health, University of Copenhagen, Copenhagen, Denmark
                [16 ]Centre for Research in Environmental Epidemiology, Barcelona, Spain
                [17 ]CIBER Epidemiología y Salud Pública, Barcelona, Spain
                [18 ]National School of Public Health, Athens, Greece
                [19 ]Environmental Chemistry Unit, Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden
                [20 ]Department of Biosciences and Nutrition, Karolinska Institute, Huddinge, Sweden
                [21 ]Laboratory for Health Protection Research, National Institute of Public Health and the Environment, Bilthoven, the Netherlands
                Author notes
                Address correspondence to J.C.S. Kleinjans, Department of Toxicogenomics, Maastricht University, Universiteitssingel 50, 6229ER Maastricht, the Netherlands. Telephone: 31433881097. E-mail: www.toxicogenomics-um.nl
                Article
                ehp.1206324
                10.1289/ehp.1206324
                3914866
                24252472
                dabb5eb6-7f67-492c-8722-6ab154f2e9e0

                Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, “Reproduced with permission from Environmental Health Perspectives”); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.

                History
                : 27 November 2012
                : 18 November 2013
                : 19 November 2013
                : 01 February 2014
                Categories
                Children's Health

                Public health
                Public health

                Comments

                Comment on this article